Discover trends, market shifts, and competitive outlooks for the antivirals industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

How Has The Antivirals Market Growth Evolved From 2024 To 2025, And What’s Ahead?

The scale of the antivirals market has notably increased in the past few years. The market which was valued at $106.13 billion in 2024 is projected to reach $114.7 billion in 2025, reflecting a compound annual growth rate (CAGR) of 8.1%. The growth observed in the historic period can be linked to the prevalence of viral diseases, widespread public health concerns, expiration of patents, and initiatives taken by the government.

In the coming years, the antivirals market size is projected to exhibit robust growth, and is anticipated to expand to a value of $153.67 billion in 2029, with a Compound Annual Growth Rate (CAGR) of 7.6%. The ascending trajectory over the forecast period is credited to burgeoning viral risks and worldwide health endeavors. Prominent trends within the forecasting timeframe include technological progress, the rise of telemedicine and digital health, as well as the adoption of personalized medicine.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2437&type=smp

What Are the Core Growth Drivers Propelling the Antivirals Market Forward?

The uptick in flu cases is expected to fuel the rise of the antiviral market. Flu, or influenza, is an extremely contagious infection of the respiratory system, brought on by influenza viruses which infect the lungs, throat and nose. Antivirals are implemented in flu treatment, created to restrict the multiplication and dispersion of these viruses within the host body. For example, the US health agency, the Centers for Disease Control and Prevention, reported in October 2022 that there were 9 million instances of flu illnesses, 4 million medical appointments related to the flu, 100,000 flu-related hospital admissions and 5,000 fatalities caused by the flu in the 2021-2022 season. Consequently, the rising occurrence of influenza is pushing the antiviral market’s expansion.

What Segment Types Define the Antivirals Market Structure?

The antivirals market covered in this report is segmented –

1) By Type: Branded, Generic

2) By Drug Class: DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Other Drug classes

3) By Application: HIV, Hepatitis, Herpes, Influenza, Other Applications

Subsegments:

1) By Branded: Antivirals For HIV Or AIDS, Antivirals For Hepatitis, Antivirals For Influenza, Antivirals For Herpes Simplex Virus (HSV)

2) By Generic: Generic HIV Or AIDS Antivirals, Generic Hepatitis Antivirals, Generic Influenza Antivirals, Generic Herpes Simplex Virus (HSV) Antivirals

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=2437&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Antivirals Market?

North America was the largest region in the anti-viral drug therapy market in 2023. The Middle East is expected to be the fastest-growing region in the antivirals market during the forecast period. The regions covered in the antivirals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Long-Term Trends Are Transforming the Competitive Landscape of the Antivirals Market?

Prominent players involved in the antiviral market are concentrating on the creation of unique therapies such as oral antiviral medication to increase patient compliance, enhance access, decrease medical expenses, and offer more user-friendly and potent alternatives for handling viral contagions. Oral antiviral treatment entails drugs that are consumed orally to manage viral diseases. This form of therapy operates by preventing the replication or proliferation of viruses within the body, thereby minimizing the intensity and length of the infection. For example, Pfizer, a pharmaceutical firm based in the United States, reported in May 2023 that the Food and Drug Administration, a US government agency, had approved Paxlovid, making it the first oral antiviral medication for adults suffering from COVID-19. This endorsement is highly relevant as it offers a novel therapeutic approach to tackle COVID-19, particularly as the pandemic is moving towards becoming an endemic. Paxlovid is specifically recommended for adults who have mild-to-moderate COVID-19 and are at a high risk of escalating to advanced illness, including hospitalization or death.

View the full report here:

https://www.thebusinessresearchcompany.com/report/antivirals-global-market-report

What Is the Definition of the Antivirals Market?

Antivirals are medications designed to treat viral infections by inhibiting the replication of viruses within the host’s cells. Unlike antibiotics, which target bacteria, antivirals are specifically used to combat viruses such as the flu, HIV, or hepatitis. They work by interfering with various stages of a virus’s lifecycle, helping to reduce the severity and duration of an infection.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2437

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model